Стр. 194 - 2

185
106. Analysis of loci required for determination of serotype antigenicity in
Streptococcus mutans and its clinical utilization / Y. Shibata [et al.] // J. Clin.
Microbiol. – 2003. – Vol. 41, № 9. – P. 4107-4112.
107. Anandarajah A.P.Anti-RANKL therapy for inflammatory bone disorders:
Mechanisms and potential clinical applications / A.P. Anandarajah,E.M.
Schwarz // J . Cell Biochem. – 2006. – Vol. 97, № 2. – P. 226-232.
108. Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks,
electron microscopy, and immunohistochemistry / J.Gamonal [et al.] // J.
Periodontol. – 2001. – Vol. 72, № 4. – P. 517-525.
109. Armitage G.C. Periodontal diagnoses / G.C. Armitage // Ann. Periodotol. –
1996. – Vol. 1. – P. 37-215.
110. Association of interleukin-1 gene polymorphisms with early onset
periodontitis / J.M. Parkhill [et al.] // J. Clin. Periodontol. – 2000. - Vol. 27. – P.
682-689.
111. B and T lymphocytes are the primary sources of RANKL in the bone
resorptive lesion of periodontal disease / T. Kawai [et al.] // Am. J. Pathol. –
2006. – Vol. 169, № 3. – P. 987-998.
112. Bacterial-responsive B lymphocytes induce periodontal bone resorption / X.
Han [et al.] // J. Immunol. – 2006. – Vol. 176, № 1. – P. 625-631.
113. Balance of inflammatory response in stable gingivitis and progressive
periodontitis lesions / T.Honda [et al.] // Clin. Exp. Immunol. – 2006. – Vol.
144, № 1. – P. 35-40.
114. Biological basis of Immunodeficiency / ed. E.W. Gelfand, H.M. Dosch. –
New-York : Raven press, 1990. – 318 p.
115. Boyce B.F .Biology of RANK, RANKL, and osteoprotegerin / B.F. Boyce,
L. Xing // Arthritis Res. Ther. – 2007. – Vol. 9, № 1. – P. 1.